| Literature DB >> 27548256 |
Andrew G Keppel1,2, Denise L Breitburg2, Rebecca B Burrell2.
Abstract
Shallow water provides important habitat for many species, but also exposes these organisms to daily fluctuations in dissolved oxygen (DO) and pH caused by cycles in the balance between photosynthesis and respiration that can contribute to repeated, brief periods of hypoxia and low pH (caused by elevated pCO2). The amplitude of these cycles, and the severity and duration of hypoxia and hypercapnia that result, can be increased by eutrophication, and are predicted to worsen with climate change. We conducted laboratory experiments to test the effects of both diel-cycling and constant low DO and pH (elevated pCO2) on growth of the juvenile eastern oyster (Crassostrea virginica), an economically and ecologically important estuarine species. Severe diel-cycling hypoxia (to 0.5 mg O2 L-1) reduced shell growth in juvenile oysters, as did constant hypoxia (1.2 and 2.0 mg O2 L-1), although effects varied among experiments, oyster ages, and exposure durations. Diel-cycling pH reduced growth only in experiments in which calcite saturation state cycled to ≤0.10 and only during the initial weeks of these experiments. In other cases, cycling pH sometimes led to increased growth rates. Comparisons of treatment effects across multiple weeks of exposure, and during a longer post-experiment field deployment, indicated that juvenile oysters can acclimate to, and in some cases compensate for initial reductions in growth. As a result, some ecosystem services dependent on juvenile oyster growth rates may be preserved even under severe cycling hypoxia and pH.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27548256 PMCID: PMC4993518 DOI: 10.1371/journal.pone.0161088
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Idealized diel cycle for laboratory experiments after Burrell et al. (2015).
Cycles are designated as: (a) ‘normoxia’, (b) ‘down-to-low’, simulated late evening, (c) ‘low plateau’–which can refer to low DO, low pH or both, simulated pre- dawn, (d) ‘up-to-normoxia’, simulated dawn, (e) ‘up-to-supersat’, simulated early afternoon, (f) ‘supersat plateau’, simulated midafternoon, (g) ‘down-to-normoxia’, simulated late afternoon. Diamond markers indicate time points where discrete measurements of DO and pH were taken in each aquarium.
Mean ± SE (n) DO and pH in oyster growth experiments.
| Treatment | DO & pH | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|
| Normoxia, | HDO: | 7.31 ± 0.02 (259) | 7.80 ± 0.02 (10) | 7.82 ± 0.05 (12) | 7.36 ± 0.02 (42) |
| Normocapnia | LDO: | 7.42 ± 0.03 (236) | 7.97 ± 0.03 (85) | 7.88 ± 0.02 (121) | 7.33 ± 0.04 (144) |
| (Control) | HpH: | 7.83 ± 0.00 (257) | 8.09 ± 0.01 (120) | 7.96 ± 0.01 (152) | 8.01 ± 0.01 (42) |
| LpH: | 7.84 ± 0.01 (242) | 8.12 ± 0.00 (85) | 7.98 ± 0.01 (128) | 7.88 ± 0.01 (144) | |
| Normoxia, cycling | HDO: | 7.31 ± 0.02 (258) | 7.78 ± 0.02 (10) | 7.84 ± 0.06 (19) | 7.41 ± 0.05 (36) |
| pH | LDO: | 7.37 ± 0.03 (238) | 7.92 ± 0.03 (85) | 7.88 ± 0.02 (119) | 7.27 ± 0.03 (138) |
| HpH: | 7.82 ± 0.00 (257) | 8.03 ± 0.00 (120) | 7.92 ± 0.01 (151) | 7.93 ± 0.01 (36) | |
| LpH: | 6.99 ± 0.00 (244) | 7.00 ± 0.01 (85) | 7.11 ± 0.00 (128) | 6.70 ± 0.00 (138) | |
| Moderate cycling | HDO: | 7.78 ± 0.02 (10) | |||
| hypoxia, | LDO: | 1.31 ± 0.01 (84) | |||
| Normocapnia | HpH: | 8.04 ± 0.01 (120) | |||
| LpH: | 8.10 ± 0.01 (85) | ||||
| Moderate cycling | HDO: | 7.30 ± 0.02 (259) | |||
| hypoxia, cycling | LDO: | 1.71 ± | |||
| pH | HpH: | 7.81 ± 0.00 (257) | |||
| LpH: | 7.04 ± 0.01 (243) | ||||
| Severe cycling | 7.26 ± 0.02 (259) | 7.77 ± 0.02 (10) | 7.84 ± 0.04 (21) | 7.35 ± 0.02 (42) | |
| hypoxia, | 0.59 ± 0.01 (236) | 0.55 ± 0.00 (84) | 0.51 ± 0.01 (128) | 0.57 ± 0.01 (138) | |
| Normocapnia | 7.81 ± 0.00 (257) | 8.03 ± 0.01 (120) | 7.93 ± 0.01 (152) | 7.90 ± 0.03 (42) | |
| 7.84 ± 0.00 (242) | 8.08 ± 0.01 (85) | 8.05 ± 0.01 (128) | 7.86 ± 0.01 (138) | ||
| Severe cycling | HDO: | 7.84 ± 0.05 (21) | |||
| hypoxia, Moderate | LDO: | 0.53 ± 0.01 (128) | |||
| cycling pH | HpH: | 7.91 ± 0.01 (152) | |||
| LpH: | 7.46 ± 0.00 (128) | ||||
| Severe cycling | HDO: | 7.32 ± 0.02 (259) | 7.76 ± 0.02 (10) | 7.83 ± 0.05 (22) | 7.31 ± 0.02 (42) |
| hypoxia, cycling | LDO: | 0.57 ± 0.01 (238) | 0.56 ± | 0.52 ± 0.01 (128) | 0.63 ± 0.01 (132) |
| pH | HpH: | 7.84 ± 0.00 (257) | 8.03 ± 0.00 (120) | 7.91 ± 0.01 (151) | 7.91 ± 0.01 (42) |
| LpH: | 7.02 ± 0.00 (244) | 6.99 ± 0.00 (85) | 7.09 ± 0.00 (126) | 6.71 ± 0.01 (132) | |
| Normoxia, | HDO: | 7.79 ± 0.01 (10) | |||
| Constant moderate | LDO: | 7.97 ± 0.03 (85) | |||
| pH | HpH: | 7.41 ± 0.01 (119) | |||
| LpH: | 7.35 ± 0.01 (85) | ||||
| Constant | HDO: | 1.28 ± 0.01 (85) | 2.07 ± 0.01 (22) | ||
| moderate/mild | LDO: | 1.28 ± 0.01 (130) | 2.09 ± 0.01 (128) | ||
| hypoxia, | HpH: | 8.05 ± 0.01 (85) | 8.02 ± 0.01 (152) | ||
| Normocapnia | LpH: | 8.05 ± 0.00 (199) | 8.03 ± 0.01 (128) |
Mean ± SE (n) DO and pH in oyster growth experiments on days on which treatment conditions cycled. High dissolved oxygen, high pH (HDO, HpH): DO and pH measured in aquaria at simulated late afternoon portion of the daily cycle when pH and DO were at or near their daily maxima in cycling treatments (i.e. high). Low dissolved oxygen, low pH (LDO, LpH): DO and pH measured in aquaria at simulated dawn when pH and DO were at their daily minima in cycling treatments (i.e. low). Empty cells are treatments which were not performed during the experiment in that column.
Starting, ending, and recovery shell area of oysters.
| Experiment year/cohort | Starting | ~2 weeks | ~4–5 weeks | 7 weeks | Recovery |
|---|---|---|---|---|---|
| 2012 | 52.6 ± 0.1, 30, | 210.6 ± 8.2, 30, | 430.1 ± 19.3, 30, | 486.9 ± 19.0, 30, | 1345.2 ± 47.9, 27, |
| (1.2–2.8) | (81.6–286.8) | (182.9–612.4) | (298.1–683.1) | (706.8–1720.7) | |
| 2013–4 weeks post-settlement cohort | 17.2 ± 1.9, 35, | 248.3 ± 14.4, 35, | 537.1 ± 31.3, 34, | ||
| (3.7–59.8) | (58.7–457.5) | (104.5960.7) | |||
| 2013–2 weeks post-settlement cohort | 3.6 ± 0.1, 35, | 153.4 ± 9.3, 35, | 437.1 ± 21.6, 34, | ||
| (1.8–5.4) | (38.9–291.7) | (120.0–731.7) | |||
| 2013–1 week post- settlement cohort | ≤1 | 95.9 ± 5.01, 35, | 340.4 ± 18.8, 34, | ||
| (37.0–142.6) | (131.4–558.0) | ||||
| 2014 | ≤1 | 12.1 ± 0.3, 48, | |||
| (8.7–18.1) | |||||
| 2015 | 10.1 ± 0.6, 24, | 71.9 ± 4.8, 24, | 291.5 ± 13.5, 24, | ||
| (5.3–18.7) | (29.4–124.2) | (194.0–435.9) |
Starting, ending, and recovery shell area (mm2) of oysters for each experiment, mean ± SE, sample size, and range (in parenthesis). Midpoint, endpoint, and recovery means are means of all replicates of all treatments. Empty cells are time points not measured in that experiment.
Summary of Ωcalcite and growth results from 2012 through 2015 experiments.
| Calcite saturation states and effects of oxygen and pH treatments on oyster growth rates | 2012 | 2013–4 weeks post settlement cohort | 2013–2 weeks post settlement cohort | 2013–1 week post settlement cohort | 2014 | 2015 |
|---|---|---|---|---|---|---|
| Ambient calcite saturation state | 1.05 | 1.87 | 1.87 | 1.87 | 0.69 | 1.01 |
| Low pH calcite saturation state | 0.19 | 0.18 | 0.18 | 0.18 | 0.10 | 0.05 |
| Severe cycling hypoxia–first part of experiment | ↔ | |||||
| Severe cycling hypoxia–second part or after experiment | ↔ | ↔ | ↔ | |||
| Constant hypoxia–first part of experiment | ||||||
| Constant hypoxia–second part of experiment | ↔ | ↔ | ||||
| Cycling pH–first part of experiment | ↔ | ↔ | ↔ | ↔ | ||
| Cycling pH–second part of experiment | ↔ | ↔ | ↔ | |||
| Constant hypercapnia | ↔ | ↔ | ↔ | |||
| Acclimation/compensation (early negative effect of hypoxia or low pH ceased or reversed later in experiment) | √ | √ | √ | √ |
Summary of Ωcalcite and growth results from 2012 through 2015 experiments. Ambient calcite saturation states were measured in the pH control treatments; Low pH calcite saturation states were measured in the cycling treatment during the low pH/low DO phase of the cycle. Upward and downward arrows without brackets indicate significant (p < 0.05) positive or negative effects of treatments, respectively. Arrows and in brackets indicate 0.05 < p < 0.1. Sideways arrows indicate no significant effect of treatment. Empty cells indicate effect was not examined in that experiment. All comparisons are relative to control conditions for that parameter.
Mean tank mortality during each of the growth experiments.
| df | F | P | |
|---|---|---|---|
| 2012 | 4, 20 | 0.82 | 0.529 |
| 2013–4 weeks post settlement | 6, 24 | 0.24 | 0.959 |
| 2013–2 weeks post settlement | 6, 24 | 0.61 | 0.719 |
| 2013–1 weeks post settlement | 6, 24 | 1.30 | 0.295 |
| 2014 | 11, 33 | 1.03 | 0.441 |
| 2015 | 3, 15 | 0.98 | 0.426 |
Randomized complete block design ANOVA of mean tank mortality during each of the growth experiments. ANOVA source and factor was treatment for all experiments. No significant effects were found.
Experimental dates, mean ± SE and range of water quality parameters in treatment aquaria during growth experiments 2012–2015.
| 2012 | 2013 | 2014 | 2015 | |
|---|---|---|---|---|
| Dates | 7/25/2012– | 8/29/2013– | 5/29/2014– | 7/2/2015– |
| 10/3/2012 | 10/8/2013 | 6/27/2014 | 8/10/2015 | |
| Salinity (PSU) | 10.66 ± 0.00 | 11.90 ± 0.01 | 6.10 ± 0.01 | 8.36 ± 0.01 |
| (9.25–12.28) | (9.2–12.93) | (5.36–6.81) | (7.22–9.47) | |
| Temperature | 29.49 ± 0.01 | 24.55 ± 0.02 | 25.08 ± 0.02 | 27.20 ± 0.03 |
| (°C) | (24.83–31.36) | (21.97–27.03) | (22.88–27.17) | (23.9–29.2) |
| Total Alkalinity | 1614.7 ± 15.8 | 1678.9 ± 4.97 | 1174.3 ± 16.03 | 1382.64 |
| (μmol kg-1 sw) | (1524.0–1700.7) | (1664.6–1692.9) | (1089.45–1273.31) | (1292.09–1505.61) |
| Chl | Algae added: | |||
| 4.272 ± 0.185 | ||||
| 4.075 ± 0.137 | (0.722–13.422) | 5.339 ± 0.103 | ||
| (1.343–9.869) | Ambient: | (2.853–8.004) | ||
| 2.829 ± 0.116 | ||||
| (0.899–11.290) |
Experimental dates, mean ± SE and range of water quality parameters in treatment aquaria during growth experiments 2012–2015. Chl a is the concentration of chlorophyll a in the water column as measured by fluorescence. Empty boxes are variables not measured during that experiment.
2012 juvenile growth experiment.
| ANCOVA Source and Factor | df | F | P |
| Starting Shell Area | 1, 9.73 | 1.84 | 0.206 |
| Treatment | 4, 22.06 | 2.67 | 0.059 |
| Contrasts | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 19 | 0.87 | 0.398 |
| Severe cycling hypoxia vs. Normoxia | 19 | 3.77 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 19 | 0.90 | 0.379 |
| Moderate cycling hypoxia vs. Normoxia | 19 | 2.50 | |
| Cycling pH vs. Normocapnia | 19 | 0.51 | 0.616 |
| ANOVA Source and Factor | df | F | P |
| Two Week Shell Area | 1, 8.304 | 0.29 | 0.606 |
| Treatment | 4, 23.843 | 5.01 | |
| Contrasts | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 19 | 2.72 | |
| Severe cycling hypoxia vs. Normoxia under Normocapnia | 19 | 2.01 | 0.059 |
| Severe cycling hypoxia vs. Normoxia under Cycling pH | 19 | 2.26 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 19 | 0.39 | 0.701 |
| Moderate cycling hypoxia vs. Normoxia | 19 | 2.43 | |
| Cycling pH vs. Normocapnia under Normoxia | 19 | 1.10 | 0.284 |
| Cycling pH vs. Normocapnia under Hypoxia | 19 | 3.95 | |
| ANOVA Source and Factor | df | F | p |
| Four Week Shell Area | 1, 18.038 | 40.14 | |
| Treatment | 4, 20.628 | 1.40 | 0.268 |
| Contrasts | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 19 | 1.40 | 0.177 |
| Severe cycling hypoxia vs. Normoxia | 19 | 0.90 | 0.380 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 19 | 0.51 | 0.616 |
| Moderate cycling hypoxia vs. Normoxia | 19 | 0.26 | 0.796 |
| Cycling pH vs. Normocapnia | 19 | 2.02 | 0.057 |
| ANOVA Source and Factor | df | F | p |
| Starting Shell Area | 1, 12.173 | 3.93 | 0.070 |
| Treatment | 4,21.181 | 2.35 | 0.087 |
| Contrast | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 19 | 0.27 | 0.790 |
| Severe cycling hypoxia vs. Normoxia | 19 | 2.68 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 19 | 2.91 | |
| Moderate cycling hypoxia vs. Normoxia | 19 | 0.63 | 0.538 |
| Cycling pH vs. Normocapnia | 19 | 0.46 | 0.653 |
| ANOVA Source and Factor | df | F | P |
| Deployment Shell Area | 1, 13.525 | 12.85 | |
| Treatment | 4, 19.244 | 4.22 | |
| Contrasts | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 16 | 0.09 | 0.932 |
| Severe cycling hypoxia vs. Normoxia | 16 | 3.39 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 16 | 2.48 | |
| Moderate cycling hypoxia vs. Normoxia | 16 | 0.33 | 0.747 |
| Cycling pH vs. Normocapnia | 16 | 1.32 | 0.205 |
| ANOVA Source and Factor | df | F | P |
| Starting Shell Area | 1, 9.729 | 0.28 | 0.611 |
| Treatment | 4, 20.179 | 0.84 | 0.517 |
| Contrast | df | T | P |
| Severe cycling hypoxia*Cycling pH Interaction | 16 | 0.30 | 0.771 |
| Severe cycling hypoxia vs. Normoxia | 16 | 0.75 | 0.463 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 16 | 0.53 | 0.606 |
| Moderate cycling hypoxia vs. Normoxia | 16 | 0.09 | 0.926 |
| Cycling pH vs. Normocapnia | 16 | 1.44 | 0.171 |
Randomized complete block design ANCOVA of instantaneous rate of growth in shell area during (A) first two weeks, (B) second two weeks, and (C) weeks four through seven of experiment using size at the start of each time interval as a covariate. (D) Randomized complete block design ANCOVA of shell area at the end of the laboratory treatment exposure using starting shell size as a covariate. (E) RCBD ANCOVA of instantaneous rate of growth in shell area during field recovery using shell area at deployment as a covariate and (F) randomized complete block design ANCOVA of mean tank juvenile oysters area at the end of the recovery period (post-nine month field deployment) with lab placement as the blocking factor and deployment area as the covariate. Tests are considered significant at a = 0.05 and significant p values are bolded.
Fig 22012 juvenile growth experiment.
Mean ± SE instantaneous rate of growth in area by treatment of juvenile oysters exposed to diel cycles 4–5 d wk-1 during (A) the first two weeks, (B) second two weeks, and (C) weeks four-seven. (D) shell area at the conclusion of the laboratory growth experiment. (E) instantaneous rate of growth during a 9-month field deployment and (F) shell area at the conclusion of the 9-month field deployment.
2013 juvenile oyster growth experiment.
| ANCOVA Source and Factor | df | F | p |
| Starting Shell Area | 1, 25.97 | 31.63 | |
| Treatment | 6, 22.24 | 1.86 | 0.133 |
| Contrasts | Df | t | p |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 0.87 | 0.393 |
| Severe cycling hypoxia vs. Normoxia | 22 | 0.40 | 0.695 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 0.28 | 0.780 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.45 | 0.660 |
| Cycling pH vs. Normocapnia | 22 | 0.79 | 0.440 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 2.15 | |
| Constant moderate hypoxia vs. Normoxia | 22 | 2.14 | |
| Constant moderate pH vs. Normocapnia | 22 | 0.79 | 0.436 |
| Constant moderate pH vs. Cycling pH | 22 | 0.03 | 0.974 |
| ANCOVA Source and Factor | df | F | p |
| Starting Shell Area | 1, 24.14 | 25.99 | |
| Treatment | 6, 23.03 | 6.80 | |
| Contrasts | Df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 23 | 0.87 | 0.395 |
| Severe cycling hypoxia vs. Normoxia | 23 | 2.07 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 23 | 0.41 | 0.684 |
| Moderate cycling hypoxia vs. Normoxia | 23 | 1.08 | 0.289 |
| Cycling pH vs. Normocapnia | 23 | 1.12 | 0.273 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 23 | 4.19 | |
| Constant moderate hypoxia vs. Normoxia | 23 | 4.94 | |
| Constant moderate pH vs. Normocapnia | 23 | 0.30 | 0.771 |
| Constant moderate pH vs. Cycling pH | 23 | 0.00 | 0.999 |
| ANOVA Source and Factor | df | F | p |
| Treatment | 6, 23 | 6.18 | |
| Contrast | Df | t | p |
| Severe cycling hypoxia*Cycling pH Interaction | 23 | 0.16 | 0.874 |
| Severe cycling hypoxia vs. Normoxia | 23 | 2.02 | 0.056 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 23 | 0.47 | 0.644 |
| Moderate cycling hypoxia vs. Normoxia | 23 | 1.59 | 0.126 |
| Cycling pH vs. Normocapnia | 23 | 0.33 | 0.745 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 23 | 3.83 | |
| Constant moderate hypoxia vs. Normoxia | 23 | 5.13 | |
| Constant moderate pH vs. Normocapnia | 23 | 1.25 | 0.224 |
| Constant moderate pH vs. Cycling pH | 23 | 1.3 | 0.206 |
| ANCOVA Source and Factor | df | F | p |
| Midpoint Shell Area | 1, 22.64 | 10.35 | |
| Treatment | 6, 22.88 | 2.52 | 0.051 |
| Contrasts | df | t | p |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 0.93 | 0.365 |
| Severe cycling hypoxia vs. Normoxia | 22 | 0.35 | 0.733 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 0.10 | 0.919 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.22 | 0.827 |
| Cycling pH vs. Normocapnia | 22 | 0.84 | 0.411 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 3.11 | |
| Constant moderate hypoxia vs. Normoxia | 22 | 2.87 | |
| Constant moderate pH vs. Normocapnia | 22 | 0.29 | 0.774 |
| Constant moderate pH vs. Cycling pH | 22 | 0.59 | 0.562 |
| ANCOVA Source and Factor | df | F | P |
| Midpoint Shell Area | 1, 2 | 0.51 | 0.484 |
| Treatment | 6, 22.18 | 0.70 | 0.650 |
| Contrasts | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 0.33 | 0.744 |
| Severe cycling hypoxia vs. Normoxia | 22 | 0.68 | 0.502 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 0.34 | 0.738 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.04 | 0.965 |
| Cycling pH vs. Normocapnia | 22 | 0.08 | 0.939 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 1.45 | 0.161 |
| Constant moderate hypoxia vs. Normoxia | 22 | 1.23 | 0.231 |
| Constant moderate pH vs. Normocapnia | 22 | 0.71 | 0.482 |
| Constant moderate pH vs. Cycling pH | 22 | 0.04 | 0.966 |
| ANOVA Source and Factor | Df | F | P |
| Midpoint Shell Area | 1, 22.31 | 0.00 | 0.986 |
| Treatment | 6, 22.20 | 0.77 | 0.604 |
| Contrast | Df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 0.10 | 0.924 |
| Severe cycling hypoxia vs. Normoxia | 22 | 1.28 | 0.214 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 0.72 | 0.481 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.38 | 0.711 |
| Cycling pH vs. Normocapnia | 22 | 0.15 | 0.879 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 1.82 | 0.083 |
| Constant moderate hypoxia vs. Normoxia | 22 | 1.67 | 0.109 |
| Constant moderate pH vs. Normocapnia | 22 | 0.21 | 0.834 |
| Constant moderate pH vs. Cycling pH | 22 | 0.24 | 0.811 |
| ANOVA Source and Factor | df | F | p |
| Starting Shell Area | 1, 24.529 | 1.98 | 0.172 |
| Treatment | 6, 22.376 | 5.35 | |
| Contrast | Df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 1.71 | 0.101 |
| Severe cycling hypoxia vs. Normoxia | 22 | 0.47 | 0.641 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 0.98 | 0.340 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.53 | 0.603 |
| Cycling pH vs. Normocapnia | 22 | 1.28 | 0.215 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 3.51 | |
| Constant moderate hypoxia vs. Normoxia | 22 | 2.97 | |
| Constant moderate pH vs. Normocapnia | 22 | 1.29 | 0.212 |
| Constant moderate pH vs. Cycling pH | 22 | 0.77 | 0.447 |
| ANOVA Source and Factor | df | F | P |
| Starting Shell Area | 1, 24.673 | 0.04 | 0.840 |
| Treatment | 6, 22.221 | 5.86 | |
| Contrast | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 22 | 0.47 | 0.642 |
| Severe cycling hypoxia vs. Normoxia | 22 | 1.49 | 0.151 |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 22 | 1.18 | 0.252 |
| Moderate cycling hypoxia vs. Normoxia | 22 | 0.13 | 0.898 |
| Cycling pH vs. Normocapnia | 22 | 0.27 | 0.793 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 22 | 4.86 | |
| Constant moderate hypoxia vs. Normoxia | 22 | 4.59 | |
| Constant moderate pH vs. Normocapnia | 22 | 0.19 | 0.848 |
| Constant moderate pH vs. Cycling pH | 22 | 0.90 | 0.377 |
| ANOVA Source and Factor | df | F | P |
| Treatment | 6, 23 | 6.57 | |
| Contrast | Df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 23 | 0.54 | 0.597 |
| Severe cycling hypoxia vs. Normoxia | 23 | 2.29 | |
| Severe cycling hypoxia vs. Moderate cycling hypoxia | 23 | 0.6 | 0.554 |
| Moderate cycling hypoxia vs. Normoxia | 23 | 1.62 | 0.120 |
| Cycling pH vs. Normocapnia | 23 | 0.76 | 0.453 |
| Constant moderate hypoxia vs. Cycling moderate hypoxia | 23 | 3.90 | |
| Constant moderate hypoxia vs. Normoxia | 23 | 5.32 | |
| Constant moderate pH vs. Normocapnia | 23 | 1.22 | 0.236 |
| Constant moderate pH vs. Cycling pH | 23 | 1.43 | 0.167 |
Randomized complete block design ANCOVA of instantaneous rate of growth in shell heights showing results from two age classes of juvenile oysters; (A) 4 weeks post-settlement, (B) 2 weeks post-settlement during first 18 days of experiment. (C) ANOVA for 18 day shell area of juvenile oysters from 1 week post-settlement oysters. (D, E, F) ANCOVA of instantaneous growth rate during second half of experiment in three age classes of oyster. (G, H), ANCOVA of shell area at the end of the 5.5-week laboratory exposure using starting shell areas as a covariate in the two older age classes of juvenile oyster. ANOVA of (I) ending oyster sizes from settlement 3:1 week post-settlement during 39 day experiment. Tests are considered significant at a = 0.05 and significant p values are bolded.
Fig 32013 juvenile growth experiment.
Mean ± 1 SE instantaneous rate of growth in shell area during first two weeks of the experiment for three age classes of juvenile oysters; (A) 4 weeks post-settlement cohort, (B) 2 weeks post-settlement cohort, and (C) 1 week post-settlement cohort. Mean ± 1 SE instantaneous rate of growth in shell area during second two weeks of the experiment for three age classes of juvenile oysters; (D) 4 weeks post-settlement cohort, (E) 2 weeks post-settlement cohort, and (F) 1 week post-settlement cohort. Mean ± 1 SE shell area of (G) 4 weeks post-settlement cohort, (H) 2 weeks post-settlement cohort, and (I) 1 week post-settlement cohort of juvenile oysters at the end of the month-long experimental exposure.
Mean ± SE, n, and range of calcite saturation states by treatment.
| Growth experiment year | |||||
|---|---|---|---|---|---|
| Treatment | DO & pH | 2012 | 2013 | 2014 | 2015 |
| Normoxia, | HDO/pH: | 1.05 ± 0.001 | 1.81 ± 0.033 | 0.68 ± 0.018 | 1.01 ± 0.029 |
| Normocapnia | 17045 | 64 | 48 | 34 | |
| (0.61–2.03) | (1.37–2.51) | (0.46–1.02) | (0.72–1.35) | ||
| Normoxia, | HDO/pH: | 1.11 ± 0.001 | 1.94 ± 0.003 | 0.66 ± 0.003 | 0.87 ± 0.002 |
| cycling pH | 8071 | 2856 | 1099 | 3525 | |
| (0.73–1.65) | (0.93–2.15) | (0.43–1.06) | (0.51–1.44) | ||
| LDO/pH: | 0.19 ± 0.000 | 0.18 ± 0.000 | 0.10 ± 0.000 | 0.05 ± 0.000 | |
| 2207 | 552 | 528 | 820 | ||
| (0.15–0.23) | (0.17–0.23) | (0.08–0.11) | (0.05–0.14) | ||
| Moderate | HDO/pH: | 1.91 ± 0.002 | |||
| cycling | 2694 | ||||
| hypoxia, | (1.58–2.24) | ||||
| Normocapnia | LDO/pH: | 2.18 ± 0.004 | |||
| 536 | |||||
| (2.02–2.46) | |||||
| Moderate | HDO/pH:: | 1.04 ± 0.001 | |||
| cycling | 7800 | ||||
| hypoxia, | (0.57–1.71) | ||||
| cycling pH | LDO/pH | 0.194 ± 0.000 | |||
| 2202 | |||||
| (0.16–0.26) | |||||
| Severe cycling | HDO/pH: | 1.00 ± 0.001 | 1.98 ± 0.001 | 0.71 ± 0.004 | 1.16 ± 0.034 |
| hypoxia, | 7800 | 2705 | 957 | 7 | |
| Normocapnia | (0.70–1.59) | (1.69–2.24) | (0.43–1.11) | (0.98–1.35) | |
| LDO/pH: | 1.13 ± 0.001 | 2.14 ± 0.003 | 0.89 ± 0.007 | 0.94 ± 0.030 | |
| 2207 | 551 | 517 | 24 | ||
| (0.99–1.24) | (1.95–2.31) | (0.58–1.18) | (0.72–1.27) | ||
| Severe cycling | HDO/pH: | 0.67 ± 0.003 | |||
| hypoxia, | 961 | ||||
| Moderate | (0.45–0.91) | ||||
| cycling pH | LDO/pH: | 0.24 ± 0.001 | |||
| 528 | |||||
| (0.20–0.27) | |||||
| Severe cycling | HDO/pH: | 1.04 ± 0.001 | 1.87 ± 0.003 | 0.68 ± 0.003 | 0.99 ± 0.002 |
| hypoxia, | 7578 | 2654 | 961 | 3459 | |
| cycling pH | (0.73–1.49) | (0.89–2.23) | (0.46–1.08) | (0.52–1.43) | |
| LDO/pH: | 0.19 ± 0.000 | 0.18 ± 0.000 | 0.10 ± 0.000 | 0.05 ± 0.000 | |
| 2196 | 551 | 528 | 756 | ||
| (0.12–0.22) | (0.15–0.23) | (0.08–0.11) | (0.05–0.14) | ||
| Normoxia, | HDO/LpH: | 0.43 ± 0.001 | |||
| Constant low | 4402 | ||||
| pH | (0.31–1.45) | ||||
| Constant | LDO/HpH: | 1.84 ± 0.003 | |||
| moderate | 4227 | ||||
| hypoxia, | (1.29–2.76) | ||||
| Normocapnia | |||||
| Constant mild | LDO/HpH: | 0.75 ± 0.002 | |||
| hypoxia, | 2743 | ||||
| Normocapnia | (0.49–1.06) | ||||
Mean ± SE, n, and range of calcite saturation states by treatment for each experiment during the simulated day and night periods, high DO/pH and the low DO/pH periods. Calcite saturation state calculated using CO2SYS.XLS [55] from ten minute average LabVIEW data. Empty boxes are treatments which were not used during the experiment in that column.
2014 juvenile oyster growth experiment.
| End Shell Area | |||
| ANOVA Source and Factor | df | F | P |
| Food Treatment*DO/pH Treatment | 5, 33 | 0.54 | 0.747 |
| DO/pH Treatment | 5, 33 | 3.68 | |
| Food Treatment | 1, 33 | 4.13 | |
| Treatment | 5,41 | 3.90 | 0.006 |
| Contrast | df | t | P |
| Severe cycling hypoxia*Cycling pH Interaction | 41 | 4.88 | |
| Severe cycling hypoxia vs. Normoxia under Normocapnia | 41 | 9.01 | |
| Severe cycling hypoxia vs. Normoxia under Severe Cycling pH | 41 | 1.33 | 0.256 |
| Constant mild hypoxia vs. Normoxia under Normocapnia | 41 | 11.79 | |
| Constant mild hypoxia vs. Cycling Severe hypoxia | 41 | 0.06 | 0.803 |
| Severe cycling pH vs. Normocapnia under Normoxia | 41 | 5.78 | |
| Severe cycling pH vs. Normocapnia under Severe cycling hypoxia | 41 | 0.02 | 0.898 |
Randomized complete block design 2-way ANOVA of DO/pH treatment by food treatment interaction (ANOVA 1) and ANOVA of shell area (ANOVA 2) from the end of the two week laboratory exposure. Tests are considered significant at a = 0.05 and significant p values are bolded.
Fig 42014 juvenile growth experiment.
Mean ± 1 SE shell area by treatment of juvenile oysters exposed to diel cycles 5–6 d wk-1 during a two-week laboratory experiment.
2015 juvenile oyster growth experiment.
| ANOVA Source and Factor | df | F | P |
| DO/pH Interaction | 1, 15 | 3.02 | 0.103 |
| DO Treatment | 1, 15 | 1.93 | 0.186 |
| pH Treatment | 1, 15 | 0.56 | 0.468 |
| ANCOVA Source and Factor | df | F | P |
| Starting Shell Area | 1, 14.063 | 3.57 | 0.080 |
| DO/pH Interaction | 1, 16.016 | 9.57 | |
| DO Treatment | 1, 15.079 | 2.24 | 0.155 |
| pH Treatment | 1, 14.34 | 5.15 | |
| Normoxia, normocapnia / Normoxia, cycling pH | 3.84 | ||
| Normoxia, normocapnia / Severe cycling DO, Normocapnia | 3.31 | ||
| Normoxia, normocapnia / Severe cycling DO, cycling pH | 2.75 | ||
| Normoxia, cycling pH / Severe cycling DO, normocapnia | 0.23 | 0.821 | |
| Normoxia, cycling pH / Severe cycling DO, cycling pH | 1.11 | 0.284 | |
| Severe cycling DO, normocapnia / Severe cycling DO, cycling pH | 0.82 | 0.425 | |
| ANCOVA Source and Factor | df | F | P |
| One Week Shell Area | 1, 16.958 | 0.20 | 0.657 |
| DO/pH Interaction | 1, 14.045 | 4.67 | |
| DO Treatment | 1, 14.486 | 4.63 | |
| pH Treatment | 1, 14.002 | 5.82 | |
| Normoxia, normocapnia / Normoxia, cycling pH | 3.39 | ||
| Normoxia, normocapnia / Severe cycling DO, Normocapnia | 3.37 | ||
| Normoxia, normocapnia / Severe cycling DO, cycling pH | 3.30 | ||
| Normoxia, cycling pH / Severe cycling DO, normocapnia | 0.11 | 0.915 | |
| Normoxia, cycling pH / Severe cycling DO, cycling pH | 0.04 | 0.968 | |
| Severe cycling DO, normocapnia / Severe cycling DO, cycling pH | 0.07 | 0.948 | |
| ANCOVA Source and Factor | df | F | P |
| Two Week Shell Area | 1, 14.278 | 24.75 | |
| DO/pH Interaction | 1, 17.255 | 2.24 | 0.152 |
| DO Treatment | 1, 16.621 | 1.72 | 0.208 |
| pH Treatment | 1, 18.903 | 7.19 | |
| ANCOVA Source and Factor | df | F | P |
| Three Week Shell Area | 1, 17.32 | 2.73 | 0.116 |
| DO/pH Interaction | 1, 14.969 | 1.20 | 0.290 |
| DO Treatment | 1, 14.515 | 6.42 | |
| pH Treatment | 1, 16.547 | 1.77 | 0.201 |
| ANCOVA Source and Factor | df | F | P |
| Four Week Shell Area | 1, 16.953 | 45.15 | |
| DO/pH Interaction | 1, 18.024 | 3.95 | 0.062 |
| DO Treatment | 1, 18.579 | 0.05 | 0.822 |
| pH Treatment | 1, 17.022 | 3.63 | 0.074 |
| Normoxia, normocapnia / Normoxia, cycling pH | 3.12 | ||
| Normoxia, normocapnia / Severe cycling DO, Normocapnia | 2.49 | ||
| Normoxia, normocapnia / Severe cycling DO, cycling pH | 2.72 | ||
| Normoxia, cycling pH / Severe cycling DO, normocapnia | 1.12 | 0.281 | |
| Normoxia, cycling pH / Severe cycling DO, cycling pH | 0.01 | 0.995 | |
| Severe cycling DO, normocapnia / Severe cycling DO, cycling pH | 1.07 | 0.303 | |
| ANCOVA Source and Factor | df | F | P |
| Starting Shell Area | 1, 9.579 | 1.91 | 0.198 |
| DO/pH Interaction | 1, 17.685 | 30.41 | |
| DO Treatment | 1, 16.156 | 64.41 | |
| pH Treatment | 1, 14.711 | 59.24 | |
| Normoxia, normocapnia / Normoxia, cycling pH | 9.50 | ||
| Normoxia, normocapnia / Severe cycling DO, Normocapnia | 9.19 | ||
| Normoxia, normocapnia / Severe cycling DO, cycling pH | 11.43 | ||
| Normoxia, cycling pH / Severe cycling DO, normocapnia | 0.65 | 0.526 | |
| Normoxia, cycling pH / Severe cycling DO, cycling pH | 1.86 | 0.084 | |
| Severe cycling DO, normocapnia / Severe cycling DO, cycling pH | 1.09 | 0.296 | |
(A) Randomized complete block design 2-way ANOVA of DO/pH treatment on starting shell area of oysters. (B-F) Randomized complete block design 2-way ANCOVA of DO/pH treatment effects on instantaneous rate of growth of juvenile oysters during each of the five weeks of the experiment. (G) Randomized complete block design 2-way ANOVA of DO/pH treatments on shell area at the end of the 5-week experimental period. Tests are considered significant at a = 0.05 and significant p values are bolded.
Fig 52015 juvenile growth experiment.
Mean ± 1 SE instantaneous rate of growth by treatment of juvenile oysters exposed to diel cycles 7 d wk-1 during (A) first week, (B) second week, (C) third week, (D) fourth week, (E) fifth week, and (F) mean ± 1 SE shell area at the end of the five week laboratory exposure.